|
US5683981A
(en)
|
1987-05-22 |
1997-11-04 |
Competitive Technologies, Inc. |
Cyclic bridged analogs of α-MSH and methods thereof
|
|
EP0292291B1
(en)
|
1987-05-22 |
1994-08-10 |
University Patents, Inc. |
Linear and cyclic analogs of alpha-msh fragments with extraordinary potency
|
|
US5674839A
(en)
|
1987-05-22 |
1997-10-07 |
Competitive Technologies, Inc. |
Cyclic analogs of alpha-MSH fragments
|
|
US5192746A
(en)
|
1990-07-09 |
1993-03-09 |
Tanabe Seiyaku Co., Ltd. |
Cyclic cell adhesion modulation compounds
|
|
US6100048A
(en)
|
1992-04-10 |
2000-08-08 |
Oregon Health Sciences University |
Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
|
|
WO1994022460A1
(en)
|
1993-04-05 |
1994-10-13 |
University Patents, Inc. |
Diagnosis and treatment of erectile dysfunction
|
|
US5731408A
(en)
|
1995-04-10 |
1998-03-24 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Peptides having potent antagonist and agonist bioactivities at melanocortin receptors
|
|
US6054556A
(en)
|
1995-04-10 |
2000-04-25 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Melanocortin receptor antagonists and agonists
|
|
US7396814B2
(en)
|
1995-06-07 |
2008-07-08 |
Palatin Technologies, Inc. |
Metallopeptide compositions for treatment of sexual dysfunction
|
|
CA2158425C
(en)
|
1995-09-15 |
2003-01-28 |
Mac E. Hadley |
Diagnostic and treatment of erectile dysfunction
|
|
IL118003A0
(en)
|
1996-04-23 |
1996-08-04 |
Yeda Res & Dev |
Novel vip fragments and pharmaceutical compositions comprising them
|
|
JP2001506996A
(ja)
|
1996-12-17 |
2001-05-29 |
クアドラント ホールディングス ケンブリッジ リミテッド |
メラノコルチン受容体３、４又は５の特異結合のためのメラノコルチン誘導体
|
|
WO1999021571A1
(en)
|
1997-10-27 |
1999-05-06 |
Trega Biosciences, Inc. |
Melanocortin receptor ligands and methods of using same
|
|
US20020099003A1
(en)
|
1997-10-28 |
2002-07-25 |
Wilson Leland F. |
Treatment of female sexual dysfunction with vasoactive agents, particularly vasoactive intestinal polypeptide and agonists thereof
|
|
GB9808229D0
(en)
|
1998-04-17 |
1998-06-17 |
Quadrant Holdings Cambridge |
Melanocortin receptor ligands
|
|
US6534503B1
(en)
|
1998-04-28 |
2003-03-18 |
Lion Bioscience Ag |
Melanocortin receptor-3 ligands to treat sexual dysfunction
|
|
US6284735B1
(en)
|
1998-04-28 |
2001-09-04 |
Lion Bioscience Ag |
HP-3228 and related peptides to treat sexual dysfunction
|
|
SE9801571D0
(sv)
|
1998-05-05 |
1998-05-05 |
Wapharm Ab |
Melanokortin-1-receptorselektiva föreningar
|
|
SE9804614A0
(en)
|
1998-07-06 |
2000-01-07 |
A+ Science Invest Ab |
New peptides and use thereof
|
|
GB9816234D0
(en)
|
1998-07-24 |
1998-09-23 |
William Harvey Research Limite |
Compounds for use in the treatment of inflammation
|
|
GB9827500D0
(en)
|
1998-12-14 |
1999-02-10 |
Wapharm Ab |
Compounds for control of eating, growth and body weight
|
|
JP2002533111A
(ja)
|
1998-12-23 |
2002-10-08 |
メルク エンド カムパニー インコーポレーテッド |
ヒトメラノコルチン１受容体タンパク質のスプライス変化体をコードするｄｎａ分子
|
|
US6887846B2
(en)
|
1999-03-24 |
2005-05-03 |
Zengen, Inc. |
Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
|
|
CA2368431C
(en)
|
1999-03-29 |
2006-01-24 |
The Procter & Gamble Company |
Melanocortin receptor ligands
|
|
CN1367792A
(zh)
*
|
1999-06-25 |
2002-09-04 |
研究及应用科学协会股份有限公司 |
促生长素抑制素激动剂
|
|
US6579968B1
(en)
|
1999-06-29 |
2003-06-17 |
Palatin Technologies, Inc. |
Compositions and methods for treatment of sexual dysfunction
|
|
US7235625B2
(en)
|
1999-06-29 |
2007-06-26 |
Palatin Technologies, Inc. |
Multiple agent therapy for sexual dysfunction
|
|
US7176279B2
(en)
|
2000-06-28 |
2007-02-13 |
Palatin Technologies, Inc. |
Cyclic peptide compositions and methods for treatment of sexual dysfunction
|
|
US6699873B1
(en)
|
1999-08-04 |
2004-03-02 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
|
US7049398B1
(en)
|
1999-08-12 |
2006-05-23 |
Palatin Technologies, Inc. |
Melanocortin metallopeptide constructs, combinatorial libraries and applications
|
|
WO2001030808A1
(en)
|
1999-10-27 |
2001-05-03 |
The Regents Of The University Of California |
Methods and compounds for modulating melanocortin receptor-ligand binding
|
|
US20030064921A1
(en)
|
1999-10-27 |
2003-04-03 |
The Regents Of The University Of California |
Methods and compounds for modulating melanocortin receptor ligand binding and activity
|
|
AU2001229491A1
(en)
|
2000-01-18 |
2001-07-31 |
Merck And Co., Inc. |
Cyclic peptides as potent and selective melanocortin-4 receptor antagonists
|
|
US6600015B2
(en)
|
2000-04-04 |
2003-07-29 |
Hoffmann-La Roche Inc. |
Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity
|
|
AU2001261363A1
(en)
|
2000-05-09 |
2001-11-20 |
The Regents Of The University Of California |
Methods and compounds for modulating melanocortin receptor ligand binding and activity
|
|
GB0012370D0
(en)
|
2000-05-22 |
2000-07-12 |
Quadrant Holdings Cambridge |
Peptoids
|
|
SI1315750T1
(sl)
|
2000-08-30 |
2007-06-30 |
Hoffmann La Roche |
Cikliäśni peptidi kot agonisti za receptorje melanokortina-4
|
|
EP1409540A2
(en)
|
2000-09-27 |
2004-04-21 |
The Procter & Gamble Company |
Melanocortin receptor ligands
|
|
US20030113263A1
(en)
|
2001-02-13 |
2003-06-19 |
Oregon Health And Sciences University, A Non-Profit Organization |
Methods and reagents for using mammalian melanocortin receptor antagonists to treat cachexia
|
|
ITMI20011057A1
(it)
|
2001-05-22 |
2002-11-22 |
Bracco Imaging Spa |
Preparazione ed uso di peptidi ciclici e ramificati e loro deriati marcati come agenti terapeutici agonisti o antagonisti della colecistochi
|
|
US7342089B2
(en)
|
2001-07-11 |
2008-03-11 |
Palatin Technologies, Inc. |
Cyclic peptides for treatment for cachexia
|
|
EP1441750A4
(en)
|
2001-07-11 |
2006-10-18 |
Palatin Technologies Inc |
LINEAR AND CYCLIC PEPTIDES SPECIFIC TO THE MELANOCORTIN RECEPTOR
|
|
US7345144B2
(en)
|
2001-07-11 |
2008-03-18 |
Palatin Technologies, Inc. |
Cyclic peptides for treatment of cachexia
|
|
US6960646B2
(en)
*
|
2001-07-12 |
2005-11-01 |
Merck & Co., Inc. |
Cyclic peptides as potent and selective melanocortin-4 receptors agonists
|
|
AU2002331064B2
(en)
*
|
2001-08-10 |
2007-08-23 |
Palatin Technologies, Inc. |
Peptidomimetics of biologically active metallopeptides
|
|
FR2835528B1
(fr)
|
2002-02-01 |
2004-03-12 |
Inst Europ Biolog Cellulaire |
Nouveaux derives peptidiques, leur preparation et leur application therapeutique et cosmetique
|
|
US20030186249A1
(en)
|
2002-04-01 |
2003-10-02 |
Zairen Sun |
Human TARPP genes and polypeptides
|
|
US7034004B2
(en)
|
2002-05-07 |
2006-04-25 |
University Of Florida |
Peptides and methods for the control of obesity
|
|
WO2004005324A2
(en)
|
2002-07-09 |
2004-01-15 |
Palatin Technologies, Inc. |
Peptide composition for treatment of sexual dysfunction
|
|
WO2004046166A2
(en)
|
2002-11-14 |
2004-06-03 |
Zengen, Inc. |
Modified alpha-msh peptides and derivatives thereof
|
|
US7135548B2
(en)
|
2002-11-14 |
2006-11-14 |
Zengen, Inc. |
Modified α-MSH peptides and derivatives thereof
|
|
BRPI0409976A
(pt)
*
|
2003-05-09 |
2006-05-09 |
Novo Nordisk As |
composto, métodos para retardar a progressão de igt diabetes do tipo 2, para retardar a progressão de diabetes do tipo 2 para diabetes que requer insulina, para tratar obesidade ou prevenir excesso de peso para regular o apetite para induzir saciedade, para prevenir ganho de peso após se ter tido sucesso em perder peso, para aumentar dispêndio de energia, para tratar uma doença ou estado e para tratar bulimia, composição farmacêutica, e, uso de um composto
|
|
KR20060026011A
(ko)
*
|
2003-05-09 |
2006-03-22 |
노보 노르디스크 에이/에스 |
비만 치료용 펩티드
|
|
EP1644022A1
(en)
|
2003-06-19 |
2006-04-12 |
Eli Lilly And Company |
Uses of melanocortin-3 receptor (mc3r) agonist peptides
|
|
EP1644023A2
(en)
|
2003-06-19 |
2006-04-12 |
Eli Lilly And Company |
Melanocortin recptor 4(mc4) agonists and their uses
|
|
US7084111B2
(en)
|
2003-06-23 |
2006-08-01 |
University Of Florida Research Foundation, Inc. |
Melanocortin receptor templates, peptides, and use thereof
|
|
US20050026948A1
(en)
|
2003-07-29 |
2005-02-03 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising an anticholinergic and a betamimetic
|
|
EP1658285B1
(en)
|
2003-08-20 |
2007-05-02 |
Eli Lilly And Company |
Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
|
|
EP1670815A2
(en)
|
2003-09-30 |
2006-06-21 |
Novo Nordisk A/S |
Melanocortin receptor agonists
|
|
EP1685102A4
(en)
|
2003-11-12 |
2008-08-20 |
Lg Life Sciences Ltd |
melanocortin
|
|
DK1689349T3
(da)
|
2003-11-24 |
2013-12-02 |
Clinuvel Pharmaceuticals Ltd |
Fremgangsmåde til induktion af melanogenese i mennesker med variante MC1R-alleler
|
|
WO2005060985A1
(en)
|
2003-12-10 |
2005-07-07 |
Merck & Co., Inc. |
Inhibition of voluntary ethanol consumption with selective melanocortin 4-receptor agonists
|
|
WO2005090388A1
(en)
*
|
2004-03-19 |
2005-09-29 |
The University Of Queensland |
Alpha helical mimics, their uses and methods for their production
|
|
JP2007530674A
(ja)
|
2004-03-29 |
2007-11-01 |
イーライ リリー アンド カンパニー |
連続注入によって投与されるメラノコルチン−４受容体（ｍｃ４ｒ）アゴニストペプチドの使用
|
|
CN1563076A
(zh)
|
2004-04-02 |
2005-01-12 |
西南生物工程产业化中试基地有限公司 |
一种用于治疗性功能障碍的α－MSH类似物及制备方法
|
|
US7442693B2
(en)
|
2004-05-28 |
2008-10-28 |
Smithkline Beecham Corporation |
Diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors
|
|
NZ582130A
(en)
|
2004-08-04 |
2011-11-25 |
Clinuvel Pharmaceuticals Ltd |
Methods of inducing melanogenesis in a subject
|
|
TW200626611A
(en)
|
2004-09-20 |
2006-08-01 |
Lonza Ag |
Peptide cyclisation
|
|
CA2582607C
(en)
|
2004-10-08 |
2016-07-12 |
Clinuvel Pharmaceuticals Limited |
Compositions and methods for inducing melanogenesis in a subject
|
|
RS51789B
(sr)
|
2004-10-25 |
2011-12-31 |
Centocor Ortho Biotech Inc. |
Mimetička tela koja vezuju receptore melanokortina, smese, postupci i upotrebe
|
|
CN101052650A
(zh)
|
2004-11-04 |
2007-10-10 |
诺和诺德公司 |
用于治疗肥胖的新颖的肽类
|
|
JP2008519006A
(ja)
|
2004-11-04 |
2008-06-05 |
ノボ ノルディスク アクティーゼルスカブ |
肥満症の治療に使用するためのペプチド
|
|
US20110098213A1
(en)
|
2004-11-04 |
2011-04-28 |
Novo Nordisk A/S |
Novel peptides for use in the treatment of obesity
|
|
CN101052649A
(zh)
|
2004-11-04 |
2007-10-10 |
诺和诺德公司 |
用于治疗肥胖的肽类
|
|
WO2006060873A1
(en)
|
2004-12-09 |
2006-06-15 |
Prince Henry's Institute Of Medical Research |
Method for restoring reproductive function
|
|
WO2006073771A2
(en)
|
2005-01-05 |
2006-07-13 |
Eli Lilly And Company |
Polyethylene glycol linked mc4r or mc3r agonist peptides
|
|
US7563781B2
(en)
|
2005-01-14 |
2009-07-21 |
Janssen Pharmaceutica Nv |
Triazolopyrimidine derivatives
|
|
WO2006097526A1
(en)
|
2005-03-17 |
2006-09-21 |
Novo Nordisk A/S |
Compounds for use in the treatment of obesity
|
|
CN101203527A
(zh)
|
2005-05-31 |
2008-06-18 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
主链环化的促黑皮质素激素（αMSH）类似物
|
|
JP2009500426A
(ja)
|
2005-07-08 |
2009-01-08 |
ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス |
メラノコルチン受容体のリガンド
|
|
NZ565217A
(en)
|
2005-07-08 |
2010-03-26 |
Ipsen Pharma Sas |
Melanocortin receptor ligands
|
|
CN1709906A
(zh)
|
2005-07-15 |
2005-12-21 |
中国科学技术大学 |
α－促黑激素的环状类似肽及其应用
|
|
CN101222942A
(zh)
|
2005-07-18 |
2008-07-16 |
诺沃-诺迪斯克有限公司 |
用于治疗肥胖的肽
|
|
CN101273059B
(zh)
|
2005-08-26 |
2014-02-19 |
艾伯维有限公司 |
治疗活性的α-MSH类似物
|
|
EP1957096A4
(en)
|
2005-08-29 |
2012-03-21 |
Palatin Technologies Inc |
CYCLIC PEPTIDE INSULATION BY SPRAY DRYING
|
|
WO2007035474A2
(en)
|
2005-09-15 |
2007-03-29 |
Novomed Technologies, Inc. (Shanghai) |
Transdermal delivery peptides and method of use thereof
|
|
US8114844B2
(en)
*
|
2006-03-30 |
2012-02-14 |
Palatin Technologies, Inc. |
Linear and cyclic melanocortin receptor-specific peptidomimetics
|
|
WO2008025074A1
(en)
*
|
2006-08-28 |
2008-03-06 |
Clinuvel Pharmaceuticals Limited |
Method for reducing incidence or rate of development of skin cancers and related conditions
|
|
AU2006350707A1
(en)
|
2006-11-08 |
2008-05-15 |
Chongxi Yu |
Transdermal delivery systems of peptides and related compounds
|
|
US7879894B2
(en)
*
|
2006-11-28 |
2011-02-01 |
Warsaw Orthopedic, Inc. |
Use of anti-cytokine agents for treating carpal and tarsal tunnel syndrome
|
|
US20100022446A1
(en)
|
2007-01-18 |
2010-01-28 |
Novo Nordisk A/S |
Use of Peptides in Combination with Surgical Intervention for the Treatment of Obesity
|
|
US20100016238A1
(en)
|
2007-01-18 |
2010-01-21 |
Novo Nordisk A/S |
Peptides for Use in the Treatment of Obesity
|
|
EP2106407A2
(en)
|
2007-01-18 |
2009-10-07 |
Novo Nordisk A/S |
Novel peptides for use in the treatment of obesity
|
|
US20100056433A1
(en)
|
2007-01-18 |
2010-03-04 |
Novo Nordisk A/S |
Novel Peptides for Use in the Treatment of Obesity
|
|
WO2008087186A2
(en)
|
2007-01-18 |
2008-07-24 |
Novo Nordisk A/S |
Peptides for use in the treatment of obesity
|
|
KR101120227B1
(ko)
|
2007-03-16 |
2012-03-20 |
화이자 리미티드 |
5-［3-（3-하이드록시페녹시）아제티딘-1-일］-5-메틸-2,2-다이페닐-헥산아마이드의 염산염
|
|
FR2914646A1
(fr)
|
2007-04-04 |
2008-10-10 |
Neorphys Soc Par Actions Simpl |
Analogues peptidiques des recepteurs des melanocortines
|
|
EP2167112A4
(en)
*
|
2007-06-15 |
2012-01-25 |
Ipsen Pharma Sas |
CYCLIC PEPTIDE MELANOCORTIN RECEPTOR LIGANDS
|
|
EP2197444A1
(en)
|
2007-09-12 |
2010-06-23 |
Glaxo Group Limited |
Novel combination of therapeutic agents
|
|
BRPI0819188B1
(pt)
|
2007-11-05 |
2021-06-22 |
Ipsen Pharma S.A.S. |
Uso de melanocortinas para a preparação de um medicamento para tratar resistência à insulina
|
|
WO2009151383A1
(en)
|
2008-06-09 |
2009-12-17 |
Palatin Technologies, Inc. |
Melanocortin receptor-specific peptides for the treatment of obesity and other diseases associated with melanocortin receptor function
|
|
KR101687037B1
(ko)
*
|
2008-06-09 |
2016-12-15 |
팔라틴 테크놀로지스 인코포레이티드 |
성기능 장애 치료용 멜라노코르틴 수용체-특이적 펩티드
|
|
EP2440572B1
(en)
|
2009-06-08 |
2017-04-05 |
Palatin Technologies, Inc. |
Lactam-bridged melanocortin receptor-specific peptides
|
|
UY32690A
(es)
|
2009-06-08 |
2011-01-31 |
Astrazeneca Ab |
Péptidos específicos para receptores de melanocortina
|
|
CA2761607C
(en)
*
|
2009-06-08 |
2018-09-04 |
Yi-Qun Shi |
Melanocortin receptor-specific peptides
|
|
JP5999702B2
(ja)
*
|
2009-11-23 |
2016-09-28 |
パラティン テクノロジーズ, インコーポレイテッドPalatin Technologies, Inc. |
メラノコルチン−１受容体特異的環状ペプチド
|
|
BR112012011780A2
(pt)
*
|
2009-11-23 |
2019-09-24 |
Palatin Technologies, Inc |
peptídeo linear,composição farmacêutica,métodopara tratamento de umadoença,indicação,condição ou sídrome mediadsa por receptor de melanocortina emum mamífero humano ou não humano e método para tratamento de uma condição responsiva ás alterações em função de receptor de melanocortina em um mamifero humano ou não humano
|